[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289-910-0850", "fax": "905-481-2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2023, "totalPay": 546345, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2023, "totalPay": 215295, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2023, "totalPay": 376767, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 61, "title": "Chief Medical Officer & Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 545222, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.99, "open": 2.03, "dayLow": 1.96, "dayHigh": 2.08, "regularMarketPreviousClose": 1.99, "regularMarketOpen": 2.03, "regularMarketDayLow": 1.96, "regularMarketDayHigh": 2.08, "beta": 0.711, "forwardPE": -6.516129, "volume": 211160, "regularMarketVolume": 211160, "averageVolume": 407556, "averageVolume10days": 356000, "averageDailyVolume10Day": 356000, "bid": 2.0, "ask": 2.04, "bidSize": 100, "askSize": 200, "marketCap": 138104976, "fiftyTwoWeekLow": 0.55, "fiftyTwoWeekHigh": 2.17, "fiftyDayAverage": 1.7489, "twoHundredDayAverage": 1.16259, "currency": "USD", "enterpriseValue": 103145352, "floatShares": 65190472, "sharesOutstanding": 68268704, "sharesShort": 275235, "sharesShortPriorMonth": 272976, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.004, "heldPercentInsiders": 0.04422, "heldPercentInstitutions": 0.13469, "shortRatio": 0.99, "shortPercentOfFloat": 0.0042, "impliedSharesOutstanding": 68368800, "bookValue": 0.432, "priceToBook": 4.6759257, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -28128292, "trailingEps": -0.32, "forwardEps": -0.31, "enterpriseToEbitda": -3.486, "52WeekChange": 2.2096775, "SandP52WeekChange": 0.24486005, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CRDL", "underlyingSymbol": "CRDL", "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "firstTradeDateEpochUtc": 1547562600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ee9d962b-eed4-3063-8df9-c815990fe5d8", "messageBoardId": "finmb_424954803", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.02, "targetHighPrice": 9.04, "targetLowPrice": 6.03, "targetMeanPrice": 7.53, "targetMedianPrice": 7.53, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 34931776, "totalCashPerShare": 0.512, "ebitda": -29590240, "totalDebt": 174340, "quickRatio": 4.245, "currentRatio": 4.358, "debtToEquity": 0.617, "returnOnAssets": -0.37710997, "returnOnEquity": -0.69929004, "freeCashflow": -14986288, "operatingCashflow": -25180440, "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2024-05-07"}]